The two justifications for the FDA’s proposed product standard prohibiting menthol cigarettes and cigars are (1) it will reduce youth initiation, and (2) it will help menthol smokers to quit. Now Sarah Mills and colleagues have published a review and meta-analysis of the effects of menthol bans around the world, The Impact of Menthol CigaretteContinue reading “Banning menthol leads a quarter of menthol smokers to quit”
Tag Archives: tobacco
Relevant to COP10: Pharmaceuticalisation as the tobacco industry’s endgame
Yogi Hendlin, Eileen Han and Pam Ling’s new paper Pharmaceuticalisation as the tobacco industry’s endgame provides a detailed analysis of how the multinational tobacco companies have developed and used the companies efforts to reposition themselves a source for “clean” nicotine while simultaneously maintaining and expanding their sales of cigarettes and other “traditional” tobacco products whereContinue reading “Relevant to COP10: Pharmaceuticalisation as the tobacco industry’s endgame”
COP10 delegates need to base decisions on latest e-cig evidence, not the same old studies e-cig advocates promote
In the lead up to the WHO Framework Convention on Tobacco Control Tenth Conference of the Parties that starts today, advocates for e-cigarettes and other “reduced harm” tobacco products have been busy again arguing that delegates should embrace these products. In reviewing some of this material, I have been struck by the fact that theirContinue reading “COP10 delegates need to base decisions on latest e-cig evidence, not the same old studies e-cig advocates promote”
Replacing 50% of cigs with ecigs or HTP had no lung benefit
E-cigarette advocates and tobacco harm reduction advocates, as well as the FDA, have long promoted a 50% reduction in cigarette smoking as a positive outcome when assessing the value of e-cigarettes (recent example). The FDA’s use of this benchmark is particularly surprising because in 2021 FDA scientists published a meta-analysis of the effects of smokers reducingContinue reading “Replacing 50% of cigs with ecigs or HTP had no lung benefit”
E-cigarettes associated with heart attacks in never smokers
Since we published the first study demonstrating that e-cigarette use was associated with higher odds of having had a heart attack, e-cigarette advocates have argued that this association was an artifact of current or former cigarette smoking or “reverse causation” due to smokers starting to use e-cigarettes after they had a heart attack. Now TalalContinue reading “E-cigarettes associated with heart attacks in never smokers”
Ecigs increased health costs by $15.1 billion in 2018
Until now we have not had direct estimates of the costs of treating the excess disease that e-cigarettes cause. Now, Yingning Wang and her UCSF colleagues have published Healthcare utilisation and expenditures attributable to current e-cigarette use among US adults that applies the same well-established methods they have used to estimate the medical costs of smokingContinue reading “Ecigs increased health costs by $15.1 billion in 2018”
More evidence that ecigs cause lung disease in youth like cigs; dual use is worse
Richa Mukerjee and colleagues’ new paper, “ENDS, cigarettes, and respiratory illness: Longitudinal associations among US youth,” adds strong evidence to the conclusion that e-cigarettes cause lung disease (bronchitis, pneumonia, or chronic cough) among young people (age 12-17). They used 6 years of longitudinal data (where you follow the same people forward in time) to measureContinue reading “More evidence that ecigs cause lung disease in youth like cigs; dual use is worse”
Stanton Glantz blog 